Page last updated: 2024-09-03

y 27632 and vardenafil dihydrochloride

y 27632 has been researched along with vardenafil dihydrochloride in 2 studies

Compound Research Comparison

Studies
(y 27632)
Trials
(y 27632)
Recent Studies (post-2010)
(y 27632)
Studies
(vardenafil dihydrochloride)
Trials
(vardenafil dihydrochloride)
Recent Studies (post-2010) (vardenafil dihydrochloride)
1,9243891780151289

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albersen, M; Bivalacqua, TJ; Bollen, I; BrĂ´ne, B; De Ridder, DJ; Falter, M; Linsen, L; Sandner, P; Tinel, H; Uvin, P; Van der Aa, F; Van Renterghem, K; Weyne, E1
Thoma, C1

Other Studies

2 other study(ies) available for y 27632 and vardenafil dihydrochloride

ArticleYear
Additive effects of the Rho kinase inhibitor Y-27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
    BJU international, 2017, Volume: 119, Issue:2

    Topics: Amides; Drug Synergism; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Middle Aged; Penis; Phosphodiesterase 5 Inhibitors; Pyridines; rho-Associated Kinases; Treatment Failure; Vardenafil Dihydrochloride

2017
Erectile dysfunction: Too much ROCK - erection block.
    Nature reviews. Urology, 2017, Volume: 14, Issue:1

    Topics: Amides; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Pyridines; rho-Associated Kinases; Vardenafil Dihydrochloride

2017